243 related articles for article (PubMed ID: 37875811)
1. Sex- and reproductive status-specific relationships between body composition and non-alcoholic fatty liver disease.
Cao YT; Zhang WH; Lou Y; Yan QH; Zhang YJ; Qi F; Xiang LL; Lv TS; Fang ZY; Yu JY; Zhou XQ
BMC Gastroenterol; 2023 Oct; 23(1):364. PubMed ID: 37875811
[TBL] [Abstract][Full Text] [Related]
2. The Prevalence Rate of Adult Sarcopenic Obesity and Correlation of Appendicular Skeletal Muscle Mass Index with Body Mass Index, Percent Body Fat, Waist-Hip Ratio, Basal Metabolic Rate, and Visceral Fat Area.
Luo X; Cai B; Jin W
Metab Syndr Relat Disord; 2023 Feb; 21(1):48-56. PubMed ID: 36318808
[No Abstract] [Full Text] [Related]
3. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.
Khamseh ME; Malek M; Abbasi R; Taheri H; Lahouti M; Alaei-Shahmiri F
Metab Syndr Relat Disord; 2021 Apr; 19(3):167-173. PubMed ID: 33259744
[No Abstract] [Full Text] [Related]
4. Gender Differences in Liver Steatosis and Fibrosis in Overweight and Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease before and after 8 Weeks of Very Low-Calorie Ketogenic Diet.
Rinaldi R; De Nucci S; Donghia R; Donvito R; Cerabino N; Di Chito M; Penza A; Mongelli FP; Shahini E; Zappimbulso M; Pesole PL; Coletta S; Triggiani V; Cozzolongo R; Giannelli G; De Pergola G
Nutrients; 2024 May; 16(10):. PubMed ID: 38794646
[TBL] [Abstract][Full Text] [Related]
5. Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease.
Li G; Rios RS; Wang XX; Yu Y; Zheng KI; Huang OY; Tang LJ; Ma HL; Jin Y; Targher G; Byrne CD; Pan XY; Zheng MH
Br J Nutr; 2022 Jun; 127(11):1613-1620. PubMed ID: 34176541
[TBL] [Abstract][Full Text] [Related]
6. Association of body composition fat parameters and breast density in mammography by menopausal status.
Chu A; Sung P; Lee J; Cheun JH; Hwang KT; Lee K; Kim J; Jeong J
Sci Rep; 2022 Dec; 12(1):22224. PubMed ID: 36564447
[TBL] [Abstract][Full Text] [Related]
7. Fat and fat-free mass as important determinants of body composition assessment in relation to sarcopenic obesity.
Gažarová M; Bihari M; Šoltís J
Rocz Panstw Zakl Hig; 2023; 74(1):59-69. PubMed ID: 37010407
[TBL] [Abstract][Full Text] [Related]
8. What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?
Machado MV; Policarpo S; Coutinho J; Carvalhana S; Leitão J; Carvalho A; Silva AP; Velasco F; Medeiros I; Alves AC; Bourbon M; Cortez-Pinto H
Obes Surg; 2020 Feb; 30(2):560-568. PubMed ID: 31637670
[TBL] [Abstract][Full Text] [Related]
9. Association of low skeletal muscle mass with advanced liver fibrosis in patients with non-alcoholic fatty liver disease.
Kang MK; Park JG; Lee HJ; Kim MC
J Gastroenterol Hepatol; 2019 Sep; 34(9):1633-1640. PubMed ID: 30667551
[TBL] [Abstract][Full Text] [Related]
10. Fat mass to fat-free mass ratio and the risk of non-alcoholic fatty liver disease and fibrosis in non-obese and obese individuals.
Dai H; Xiang J; Hou Y; Xuan L; Wang T; Li M; Zhao Z; Xu Y; Lu J; Chen Y; Wang W; Ning G; Bi Y; Xu M
Nutr Metab (Lond); 2021 Feb; 18(1):21. PubMed ID: 33608033
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Computed Tomography-based Abdominal Adiposity Indexes as Predictors of Non-alcoholic Fatty Liver Disease Among Middle-aged Korean Men and Women.
Baek J; Jung SJ; Shim JS; Jeon YW; Seo E; Kim HC
J Prev Med Public Health; 2020 Jul; 53(4):256-265. PubMed ID: 32752595
[TBL] [Abstract][Full Text] [Related]
12. Obesity, body composition, and prostate cancer.
Fowke JH; Motley SS; Concepcion RS; Penson DF; Barocas DA
BMC Cancer; 2012 Jan; 12():23. PubMed ID: 22257467
[TBL] [Abstract][Full Text] [Related]
13. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
14. Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening.
Poustchi H; Alaei-Shahmiri F; Aghili R; Nobarani S; Malek M; Khamseh ME
Arch Iran Med; 2021 Mar; 24(3):177-186. PubMed ID: 33878875
[TBL] [Abstract][Full Text] [Related]
15. Visceral fat area to appendicular muscle mass ratio as a predictor for nonalcoholic fatty liver disease independent of obesity.
Shi YX; Chen XY; Qiu HN; Jiang WR; Zhang MY; Huang YP; Ji YP; Zhang S; Li CJ; Lin JN
Scand J Gastroenterol; 2021 Mar; 56(3):312-320. PubMed ID: 33535004
[TBL] [Abstract][Full Text] [Related]
16. Body composition, phenotype and central obesity indices in Egyptian women with non-alcoholic fatty liver disease.
Zaki M; Amin D; Mohamed R
J Complement Integr Med; 2020 Dec; 18(2):385-390. PubMed ID: 34187121
[TBL] [Abstract][Full Text] [Related]
17. Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults.
Li S; Feng L; Ding J; Zhou W; Yuan T; Mao J
BMC Gastroenterol; 2023 Nov; 23(1):376. PubMed ID: 37919650
[TBL] [Abstract][Full Text] [Related]
18. Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease.
Shida T; Akiyama K; Oh S; Sawai A; Isobe T; Okamoto Y; Ishige K; Mizokami Y; Yamagata K; Onizawa K; Tanaka H; Iijima H; Shoda J
J Gastroenterol; 2018 Apr; 53(4):535-547. PubMed ID: 28791501
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of controlled attenuation parameter and liver stiffness measurement for detecting increased arterial stiffness in asymptomatic populations in China.
Yu XY; Song XX; Tong YL; Wu LY; Song ZY
Medicine (Baltimore); 2020 Nov; 99(48):e23360. PubMed ID: 33235107
[TBL] [Abstract][Full Text] [Related]
20. The Association of Sarcopenia and Visceral Obesity with Lean Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus.
Zhang X; He Z; Si Q; Hu X; Yang L; Gu X; Du L; Wang L; Pan L; Li Y; Li J; Yang B; Gu X
J Diabetes Res; 2022; 2022():2229139. PubMed ID: 36387941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
